Real-Time Monitoring of Critical Care Analytes in the Bloodstream with Chemical Sensors: Progress and Challenges

Annual Review of Analytical Chemistry

Volumn 8, Issue , 2015, Pages 171-192

  Frost, Megan C ^a   Meyerhoff, Mark E ^b  

^a Michigan Technological University   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Carbon dioxide; Electrolytes; Ex vivo sensors; Glucoselactate; In vivo sensors; Oxygen; PH

Indexed keywords

CARBON DIOXIDE; CATHETERS; CELL ADHESION; CHEMICAL ANALYSIS; CHEMICAL SENSORS; ELECTROLYTES; OXYGEN; PH;

CRITICALLY ILLS; EX-VIVO; GLUCOSELACTATE; IN-VIVO; PERFORMANCE ISSUES; REAL TIME MONITORING; SENSOR SELECTIVITY; THROMBUS FORMATION;

BLOOD;

BLOOD ANALYSIS; DEVICES; GENETIC PROCEDURES; HUMAN; INTENSIVE CARE; PHYSIOLOGIC MONITORING; PROCEDURES;

BIOSENSING TECHNIQUES; BLOOD CHEMICAL ANALYSIS; CRITICAL CARE; HUMANS; MONITORING, PHYSIOLOGIC;

EID: 84937419921     PISSN: 19361327     EISSN: 19361335     Source Type: Book Series    
DOI: 10.1146/annurev-anchem-071114-040443     Document Type: Review

References (114)

1. Bakker E. 2004. Electrochemical sensors. Anal. Chem. 76:3285-98
2. Wolfbeis OS. 2008. Fiber-optic chemical sensors and biosensors. Anal. Chem. 80:4269-83
3. C orcoles EP, Boutelle MG. 2013. Biosensors and Invasive Monitoring in Clinical Applications. New York: Springer
4. Frost MC, Wolf AK, Meyerhoff ME. 2013. In vivo sensors for continuous monitoring of blood gases, glucose and lactate: biocompatibility challenges and potential solutions. In Detection Challenges in Clinical Diagnosis, ed. P Vadgama, S Peteu, pp. 129-55. Cambridge: RSC Publ
5. Gifford R. 2013. Continuous glucose monitoring:40 years, what we've learned and what's next. Chem. Phys. Chem. 14:2032-44
6. FrostMC, MeyerhoffME. 2002. Indwelling chemical sensors for real-time clinical monitoring: progress and challenges. Curr. Opin. Chem. Biol. 6:633-41
7. Frost MC, Meyerhoff ME. 2006. In vivo chemical sensors: tackling biocompatibility. Anal. Chem. 78:7370-77
8. Ganter M, Zollinger A. 2003. Continuous intravascular blood gas monitoring: development, current techniques, and clinical use of a commercial device. Brit. J. Anaesth. 91:397-407
9. Coule LW, Truemper EJ, Steinhart CM, Lutin WA. 2001. Accuracy and utility of a continuous intraarterial blood gas monitoring system in pediatric patients. Crit. Care Med. 29:420-26
10. Shapiro BA. 1992. In-vivo monitoring of arterial blood gases and pH. Resp. Care 37:165-69
11. Wahr JA, Tremper KK. 1994. Continuous intravascular blood gas monitoring. J. Cardiothorac. Vasc. Anesth. 8:342-53
12. Meyerhoff ME. 1993. In vivo blood-gas and electrolyte sensors: progress and challenges. Trends Anal. Chem. 12:257-66
13. Collison ME, Meyerhoff ME. 1990. Chemical sensors for bedside monitoring of critically ill patients. Anal. Chem. 62:425A-37
14. Mahutte CK, Sasson CSH, Muro JR, Hansmann DR, Maxwell TP, et al. 1990. Progress in the development of a fluorescent intravascular blood gas system in man. J. Clin. Monitoring 6:147-57
15. Divers S, Marshall W, Foster-Smith R. 1992. Advances in intra-arterial blood gas sensors. In Proc. Conf. Electrolytes, Blood Gases and Other Critical Analytes, ed. MS Burritt, SF Sena, P D'Orazio, pp. 1-9. Washington, DC: AACC
16. Weiss IK, Fink S, Harrison R, Feldman JD, Brill JE. 1999. Clinical use of continuous arterial blood gas monitoring in the pediatric intensive care unit. Pediatrics 10:440-45
17. Wilson GS,Gifford R. 2005. Biosensors for real-time in vivo measurement. Biosens. Bioelectron. 20:2388-403
18. Mo JW, Smart W. 2004. Lactate biosensors for continuous monitoring. Front. Biosci. 9:3384-91
19. YanQ,Major TC, Bartlett RH, MeyerhoffME. 2011. Intravascular glucose/lactate sensors prepared with nitric oxide releasing poly(lactide-co-glycolide)-based coatings for enhanced biocompatibility. Biosens. Bioelectron. 26:4276-82
20. Dyson A, Singer M. 2011. Tissue oxygen tension monitoring: will it fill the void? Curr. Opin. Crit. Care 17:281-89
21. Hartmann M, Montgomery A, Jönsson K, Haglund U. 1991. Tissue oxygenation in hemorrhagic shock measured as transcutaneous oxygen tension, subcutaneous oxygen tension, and gastrointestinal intramucosal pH in pigs. Crit. Care Med. 19:205-10
22. Yassin J, Singer M. 2007. Fundamental of oxygen delivery. In Acute Kidney Injury, ed. C Romnco, R Bellomo, JA Kellum, pp. 119-32. Basel: S. Kager AG
23. Bakker J, Vincent JL, Gris P, Leon M, Coffernils M, Kahn RJ. 1992. Veno-arterial carbon dioxide gradient in human septic shock. Chest 101:509-15
24. Luft FC. 2001. Lactic acidosis update for critical care clinicians. J. Am. Soc. Nephrol. 12:S15-19
25. Kraut JA, Madias NE. 2007. Serum anion gap: its uses and limitations in clinical medicine. Clin. J. Am. Soc. Nephrol. 2:162-74
26. Fletcher S, Dhrampal A. 2003. Acid-base balance and arterial blood gas analysis. Surgery 21:61-65
27. Ali R, Lang T, Saleh SM, Meier RJ, Wolfbeis OS. 2011. Optical sensing scheme for carbon dioxide using solvatochromic probe. Anal. Chem. 83:2846-51
28. Morf WE, Mostert IA, Simon W. 1985. Time response of potentiometric gas sensors to primary and interfering species. Anal. Chem. 57:1122-26
29. Kraft MD, Btaiche IF, Sacks GS, Kudsk KA. 2005. Treatment of electrolyte disorders in adult patients in the intensive care unit. Am. J. Health Syst. Pharm. 62:1665-82
30. Z'GraggenWJ, Lin CSY, Howard RS, Beale RJ, Bostock H. 2006. Nerve excitability changes in critical illness polyneuropathy. Brain 129:2461-70
31. Lindner G, Schwarz C, Grüssing H, Kneidinger N, Fazekas A, Funk GC. 2013. Rising serum sodium levels are associated with a concurrent development ofmetabolic alkalosis in critically ill patients. Intensive Care Med. 39:399-405
32. Kondepati VR, Heise HM. 2007. Recent progress in analytical instrumentation for glycemic control in diabetic and critically ill patients. Anal. Bioanal. Chem. 388:545-563
33. Valenza F, Aletti G, Fossali T, Chevallard G, Sacconi F, et al. 2005. Lactate as a marker of energy failure in critically ill patients: hypothesis. Crit. Care 9:588-93
34. Facchinetti A. 2013. Real-time improvement of continuous glucose monitoring accuracy. Diabetes Care 36:793-900
35. Tubiana-Rufi N, Riveline JP, Dardari D. 2007. Real-time continuous glucose monitoring using Guardian R RT: from research to clinical practice. Diabetes Metab. 33:415-420
36. McNelis J, Marini CP, Jurkiewicz A, Szomstein S, Simms HH, et al. 2001. Prolonged lactate clearance is associated with increased mortality in the surgical intensive care unit. Am. J. Surgery 182:481-85
37. Ramdomski MW, Moncada S. 1993. The biological and pharmocological role of nitric oxide in platelet function. In Mechanisms of Platelet Activation and Control, ed. KS Authi, SP Watson, VV Kakkar, pp. 251-64 Plenum Press: New York
38. Yim JB, Hubbard TW, Melkerson LD, Sexton MA, Fieggen BM. 1991. Configuration fiber-optic blood gas sensor bundle and method of making. US Patent No. 5,047,627
39. Amao Y. 2003. Probes and polymers for sensing oxygen. Microchim. Acta 143:1-12
40. YehTS, ChuCS, Lo Y. 2006. Highly sensitive optical fiber oxygen sensor using Pt(II) complex embedded in sol-gel matrices. Sens. Actuators B 119:701-12
41. Chu CS, Lo YL. 2010. Optical finer dissolved oxygen sensors based on Pt(II) complex and core-shell silica nanoparticles incorporated in sol-gel matrix. Sens. Actuators B 151:83-89
42. Severinghaus JW. 1968. Measurement of blood gases: PO2 and PCO2. Ann. N. Y. Acad. Sci. 148:115-32
43. JinW, Jiang J, Song Y, Bai C. 2012. Real-time monitoring of blood carbon dioxide tension by fluorosensor. Res. Physiol. Neurobiol. 180:141-46
44. Nivens DA, Schiza MV, Angel M. 2002. Multilayer sol-gel membranes for optical sensing applications: single layer pH and dual layer CO2 and NH3 sensors. Talanta 58:543-50
45. Jin W, Jiang J, Wang X, Zhu X, Wang G, et al. 2011. Continuous intra-arterial blood pH monitoring in rabbits with acid-base disorders. Res. Physiol. Neurobiol. 177:183-88
46. Offenbacher H, Wolfbeis OS, Furlinger E. 1986. Fluorescence optical sensors for continuous determination of near-neutral pH values. Sens. Actuators 9:73-84
47. Tusa JK, He H. 2005. Critical care analyzer with fluorescent optical chemosensors for blood analytes. J. Mater. Chem. 15:2640-47
48. Clark LC, Wolf R, Granger D, Taylor Z. 1953. Continuous recording of blood oxygen tensions by polarography. J. Appl. Physiol. 6:189-93
49. Kinlen PJ,Heider JE, Hubbard DE. 1994.Asolid-statepHsensor based on a Nafion-coated iridium oxide indicator electrode and a polymer-based silver chloride reference electrode. Sens. Actuators B 22:13-25
50. MeyerhoffME. 1990. New in vitro analytical approaches for clinical chemistry measurements in critical care. Clin. Chem. 36:1567-72
51. Meruva RK, Meyerhoff ME. 1998. Catheter-type sensor for potentiometric monitoring of oxygen, pH and carbon dioxide. Biosens. Bioelectron. 13:201-12
52. MakosMA, Omiatek DM, Ewing AG, HeienML. 2010. Development and characterization of a voltammetric carbon-fiber microelectrode pH sensor. Langmuir 26:10386-91
53. HuangWD, Cao H, Deb S, Chiao M, Chiao JC. 2011. A flexible pH sensor based on the iridium oxide sensing film. Sens. Actuators A 169:1-11
54. Kennedy CD. 1990. Ionic strength and the dissociation of acids. Biochem. Ed. 18:35-40
55. Oesch U, Ammann D, SimonW. 1986. Ion-selective membrane electrodes for clinical use. Clin. Chem. 32:1448-59
56. DimeskiG, Badrick T, St John A. 2010. Ion selective electrodes (ISEs) and interferences-A review. Clin. Chim. Acta 411:309-17
57. Kondepati VR, Heise HM. 2007. Recent progress in analytical instrumentation for glycemic control in diabetic and critically ill patients. Anal. Bioanal. Chem. 388:545-63
58. Wilson GS,Gifford R. 2005. Biosensors for real-time in vivo measurements. Biosens. Bioelectron. 20:2388-403
59. Mo JW, Smart W. 2004. Lactate biosensors for continuous monitoring. Front. Biosci. 9:3384-91
60. Ward WK, Jansen LB, Anderson E, Reach G, Klein JC, Wilson GS. 2002. A new amperometric glucose microsensor: in vitro and short-term in vivo evaluation. Biosens. Bioelectron. 17:181-89
61. Wang J. 2001. Glucose biosensors:40 years of advances and challenges. Electroanalysis 13:983-88
62. Koschinsky T, Heinemann L. 2001. Sensors for glucose monitoring: technical and clinical aspects. Diabetes Metab. Res. Rev. 17:113-23
63. Choleau C, Klein JC, Reach G, Aussedat B, Demaria-Pesce V, et al. 2002. Calibration of a subcutaneous amperometric glucose sensor implanted for 7 days in diabetic patients: Part2 Superiority of the onepoint calibration method. Biosens. Bioelectron. 17:647-54
64. Waeger P, Hummel M. 2008. Latest developments in continuous glucose monitoring. Diabetes Metab. Heart 17:385-91
65. Tubiana-Rufi N, Riveline JP, Dardari D. 2007. Real-time continuous glucose monitoring using Guardian R RT: from research to clinical practice. Diabetes Metab. 33:415-20
66. Hirsch IB, Armstrong D, Bergenstal RM, Buckingham B, Childs BP, et al. 2008. Clinical application of emerging sensor technologies in diabetes management: consensus guidelines for continuous glucose monitoring (CGM). Diabetes Technol. Ther. 10:232-46
67. Gough DA, Kumosa LS, Routh TL, Lin JT, Lucisano JY. 2010. Function of an implanted tissue glucose sensor for more than 1 year in animals. Sci. Transl. Med. 2:42-53
68. McNichols RJ, Cote GL. 2000. Optical glucose sensing in biological fluids: an overview. J. Biomed. Opt. 5:5-16
69. Wang J. 2008. In vivo glucosemonitoring: towards "sense and act" feedback-loop individualizedmedical systems. Talanta 75:636-41
70. Heller A. 2006. Electron-conducting redox hydrogels: design, characteristics and synthesis. Curr. Opin. Chem. Biol. 6:664-72
71. Marvin JS, Hellinga HW. 1998. Engineering biosensors by introducing fluorescent allosteric signal transducers: construction of a novel glucose sensor. J. Am. Chem. Soc. 120:7-11
72. Mansouri S, Schultz JS. 1984. A miniature optical glucose sensor based on affinity binding. Biotechnology 2:885-90
73. Tipnis R, Vaddiraju M, Jain F, Burgess D, Papadimitrakopoulos F. 2007. Layer-by-layer assembled semipermeable membranes for amperometric glucose sensors. J. Diabetes Sci. Technol. 2:193-200
74. Lin Y, Taylor S, Li H, Fernando KAS, Qu L, et al. 2004. Advances toward bioapplications of carbon nanotubes. J. Mater. Chem. 14:527-41
75. Lin YH, Lu F, Tu Y, Ren ZF. 2004. Glucose biosensors based on carbon nanotube nanoelectrode ensembles. Nano Lett. 4:191-95
76. Zhu Z, Song W, Burugapalli K, Moussy F, Li YL, Zhong XH. 2010. Nano-yarn carbon nanotube fiber based enzymatic glucose biosensor. Nanotechnology 21:165501
77. Tierney S, Falch BMH, Hjelme DR, Stokke BT. 2009. Determination of glucose levels using a functionalized hydrogel-optical fiber biosensor: toward continuous monitoring of blood glucose in vivo. Anal. Chem. 81:3630-36
78. Paek SH, Cho IH, Kim DH, Jeon JW, Lim GS, Paek SH. 2013. Label-free, needle-type biosensor for continuous glucose monitoring based on competitive binding. Biosens. Bioelectron. 40:38-44
79. Holloway P, Benham S, St. John A. 2001. The value of blood lactatemeasurement in ICU: an evaluation of the role in the management of patients on haemofiltration. Clin. Chim. Acta 307:9-13
80. Shapiro N, Howell M, Talmor D, Nathanson L, Lisbon A, et al. 2005. Serum lactate as a predictor of mortality in emergency department patients with infection. Ann. Emerg. Med. 45:524-28
81. O'Grady NP, Alexander M, Dellinger EP, Gerberding JL, Heard SO, et al. 2002. Guidelines for the prevention of intravascular catheter-related infections. Centers for Disease Control and Prevention. MMWR Recomm. Rep. 51:1-29
82. Maki DG, Kluger DM, Crnich CJ. 2006. The risk of bloodstream infection in adults with different intravascular devices: a systematic review of 200 published prospective studies. Mayo Clin. Proc. 81:1159-71
83. Nichol A, Bailey M, Egi M, Pettila V, French C, et al. 2011. Dynamic lactate indices as predictors of outcome in critically ill patients. Crit. Care 15:R242
84. Armour JC, Lucisano JY, McKean BD, Gough DA. 1990. Application of chronic intravascular blood glucose sensor in dogs. Diabetes 39:1519-26
85. Fogt E. 1990. Continuous ex vivo and in vivo monitoring with chemical sensors. Clin. Chem. 36:1573-80
86. Torjman MC, Dalal N, Goldberg ME. 2008. Glucose monitoring in acute care: technologies on the horizon. J. Diabetes Sci. Technol. 2:178-81
87. Coss-Bu JA, Jefferson LS, Stone-McCord S, Ou CN, Watrin C, et al. 1999. Evaluation of real-time blood glucose monitor in children with diabetic ketoacidosis. Diabetes Res. Clin. Prac. 44:175-81
88. YamashitaK,OkabayashiT, YokoyamaT, YatabeT,Maeda H, et al. 2008. The accuracy of a continuous blood glucose monitor during surgery. Anesth. Analg. 106:160-63
89. Torjman MC, Goldberg ME, Marr AT, Maldonado M, Littman JJ. 2007. Evaluation of an automated blood glucose monitor in cardiac surgery and critically ill ICU patients. ASA Abstr. 1127
90. Magarian P, Sterling B. 2009. Plasma-generating glucose monitor accuracy demonstrated in an animal model. J. Diabetes Sci. Technol. 3:1411-18
91. Jax T, Heise T, Nosek L, Gable J, Lim G, Calentine C. 2011. Automated near-continuous glucose monitoring measured in plasma using mid-infrared spectroscopy. J. Diabetes Sci. Technol. 5:354-52
92. Foubert LA, Lecomte PV, Nobels FR, Gulino AM, DeDecker KH. 2014. Accuracy of a feasible version of an intravenous continuous glucose monitor in volunteers with diabetes hospitalized patients. Diabetes Techno. Therap. 16:858-66
93. Dee KC, Puleo DA, Bizios R. 2002. Blood-biomaterials interactions and coagulation. In An Introduction to Tissue-Biomaterial Interactions, pp. 68-81. Hoboken, NJ: Wiley
94. Anderson JM. 2001. Biological response to materials. Annu. Rev. Mater. Res. 31:81-110
95. Andersson J, Ekdahl KN, Lambris JD, Nilsson B. 2005. Binding of C3 fragments on top of adsorbed plasma proteins during complement activation on a model biomaterial surface. Biomaterials 26:1477-85
96. Elwing H. 1998. Protein absorption and ellipsometry in biomaterials research. Biomaterials 19:397-406
97. Munker R. 2007. Basic biology of hemopoiesis. In Modern Hematology, ed. R Munker, E Hiller, J Glass, R Paquette, pp. 1-18. Totowa, NJ: Humana Press
98. Chen H, Yuan L, Song W, Wu Z, Li D. 2008. Biocompatible polymer materials: role of protein-surface interactions. Prog. Polym. Sci. 33:1059-87
99. Chen S, Li L, Zhao C, Zheng J. 2010. Surface hydration: principles and applications toward lowfouling/ non-fouling biomaterials. Polymer 51:5283-93
100. Kim P, Kim DH, Kim B, Choi SK, Lee SH, et al. 2005. Fabrication of nanostructures if polyethylene glycol for application to protein adsorption and cell adhesion. Nanobiotechnology 16:1-7
101. Li G, Cheng G, Xue H, Chen S, Zhang F, Jiang S. 2008. Ultra low fouling zwitterionic polymers with a biomimetic adhesive group. Biomaterials 29:4592-97
102. Zhang Z, Zhang M, Chen S, Horbett TA, Ratner BD, Jiang S. 2008. Blood compatibility of surfaces with superlow protein adsorption. Biomaterials 29:4285-91
103. Zhang Z, Chao T, Chen S, Jiang S. 2006 Superlow fouling sulfobetaine and carboxybetaine polymers on glass slides. Langmuir 22:10072-77
104. Zhang Z, Chen S, Jiang S. 2006. Dual-functional biomimetic materials: nonfouling poly(carboxybetaine) with active functional groups for protein immobilization. Biomacromolecules 7:3311-15
105. Ma H, Hyun J, Stiller P, Chilkoti A. 2004. "Non-fouling" oligo(ethylene glycol)-functionalized polymer brushes synthesized by surface-initiated atom transfer radical polymerization. Adv. Mater. 16:338-41
106. Zhang Z,Chen S,Chang Y, Jiang S. 2006. Surface grafted sulfobetaine polymers via atom transfer radical polymerization as superlow fouling coatings. J. Phys. Chem. B 110:10799-804
107. Finley MJ, Rauova L, Alferiev IS, Weisel JW, Levy RJ, Stachelek SJ. 2012. Diminished adhesion and activation of platelets and neutrophils with CD47 functionalized blood contacting surfaces. Biomaterials 33:5803-11
108. Finley MJ, Clark KA, Alferiev IS, Levy RJ, Stachelek SJ. 2013. Intracellular signaling mechanisms associated with CD47 modified surfaces. Biomaterials 34:8640-49
109. Frost MC, Rudich SM, Zhang HP, Maraschio MA, Meyerhoff ME. 2002. In vivo biocompatibility and analytical performance of intravascular amperometric oxygen sensors prepared with improved nitric oxide releasing silicone rubber coating. Anal. Chem. 74:5942-47
110. Zhou Z, Meyerhoff ME. 2005. Preparation and characterization of polymeric coatings with combined nitric oxide release and immobilized active heparin. Biomaterials 26:6506-17
111. Wu B, Gerlitz B, Grinnell BW, Meyerhoff ME. 2007. Polymeric coatings that mimic the endothelium: combined nitric oxide release with surface-bound active thrombomodulin and heparin. Biomaterials 28:4047-55
112. Valgimigli F, Mastrantonio F, Lucarelli F. 2014. Blood glucosemontoring systems. In Security and Privacy for Implantable Medical Devices, ed.WBurleson, S Carrara, pp. 15-82. New York: Springer
113. PR Newswire. 2014. OptiScan Biomedical enrolls first patient in pivotal U.S. clinical study of OptiScanner R 5000. News Release, Apr. 28. PR Newswire,New York. http://www.prnewswire.com/news-releases/ optiscan-biomedical-enrolls-first-patient-in-pivotal-us-clinical-study-of-optiscanner-5000-256965261.html
114. Ratner BD. 2007. The catastrophe revisited: blood compatibility in the 21st century. Biomaterials 28:5144-47